C
Christophe Carreau
Researcher at European Space Research and Technology Centre
Publications - 5
Citations - 361
Christophe Carreau is an academic researcher from European Space Research and Technology Centre. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 240 citations.
Papers
More filters
Journal ArticleDOI
Habitability on Early Mars and the Search for Biosignatures with the ExoMars Rover
Jorge L. Vago,Frances Westall,Andrew J. Coates,Ralf Jaumann,Oleg Korablev,Valérie Ciarletti,I. G. Mitrofanov,Jean-Luc Josset,Maria Cristina De Sanctis,Jean-Pierre Bibring,F. Rull,Fred Goesmann,Harald Steininger,Walter Goetz,William B. Brinckerhoff,Cyril Szopa,François Raulin,Howell G. M. Edwards,Lyle G. Whyte,Alberto G. Fairén,John Bridges,Ernst Hauber,Gian Gabriele Ori,Stephanie C. Werner,Damien Loizeau,Ruslan O. Kuzmin,Rebecca M. E. Williams,Jessica Flahaut,François Forget,Daniel Rodionov,Håkan Svedhem,Elliot Sefton-Nash,Gerhard Kminek,L. Lorenzoni,Luc Joudrier,Viktor Mikhailov,Alexander Zashchirinskiy,Sergei Alexashkin,Fabio Calantropio,Andrea Merlo,Pantelis Poulakis,Olivier Witasse,Olivier Bayle,Silvia Bayón,Uwe J. Meierhenrich,John Carter,Juan Manuel García-Ruiz,Pietro Baglioni,A. F. C. Haldemann,Andrew J. Ball,André Debus,Robert Lindner,Frédéric Haessig,David Monteiro,Roland Trautner,Christoph Voland,Pierre Rebeyre,Duncan Goulty,F. Didot,Stephen Durrant,Eric Zekri,Detlef Koschny,Andrea Toni,Gianfranco Visentin,Martin Zwick,Michel van Winnendael,Martin Azkarate,Christophe Carreau +67 more
TL;DR: The second ExoMars mission will be launched in 2020 to target an ancient location interpreted to have strong potential for past habitability and for preserving physical and chemical biosignatures (as well as abiotic/prebiotic organics).
Journal ArticleDOI
Diagnostic approach in adult-onset neurometabolic diseases
Gorka Fernández-Eulate,Christophe Carreau,Jean-François Benoist,Foudil Lamari,Benoit Rucheton,Natalia Shor,Yann Nadjar +6 more
TL;DR: A simplified diagnostic approach is proposed for the neurologist with the aim to help determine when to suspect a neurometabolic disease and how to proceed in a rational manner, and the place of next-generation sequencing technologies in the diagnostic process is discussed.
Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
Renata Ursu,Didier Maillet,Catherine Belin,Christine Moroni,Stefania Cuzzubbo,Victoria Vernier,Lila Sirven-Villaros,Christophe Carreau,Roberta Di Blasi,Catherine Thieblemont,Antoine F. Carpentier +10 more
TL;DR: No significant neurocognitive or neurologic disorders were observed in this cohort of patients, 2 years after treatment with anti-CD19 CAR T cells.
Journal ArticleDOI
Long-Term Neurological Safety in B-Cell Lymphoma Patients Treated With Anti-CD19 CAR T-Cell Therapy.
Renata Ursu,Didier Maillet,Catherine Belin,Christine Moroni,Stefania Cuzzubbo,Victoria Vernier,Lila Sirven-Villaros,Christophe Carreau,Roberta Di Blasi,Catherine Thieblemont,Antoine F. Carpentier +10 more
TL;DR: No significant neurocognitive or neurological disorders were observed in this cohort of patients, two years after treatment with anti-CD19 CAR T-cells.
Journal ArticleDOI
Impact of a Head and Neck Cancer Chemoradiation (HNC CRT) Nurse Practitioner (NP) on Patient Outcomes
A. McCready,Mary G. Quinn,Peggy Francis,Rae-Ann Stortz,Sara Kuruvilla,Paul Stewart,David A. Palma,Peter Lang,Nancy Read,Jinka Sathya,Varguar M. Venkatesan,Anthony C. Nichols,Danielle MacNeil,KC Fung,A. Méndez,Christophe Carreau,S. Hawkins,C. Parker,L. Warner,Eric Winquist +19 more
TL;DR: In this article , the impact of symptom management during and immediately post-CRT was assessed on patient Emergency Department (ER) visits, hospitalizations, hospital admission, and deaths.